Alzheimer's disease

Mass General Brigham vetoes controversial Alzheimer's drug Aduhelm after internal review
Fierce Healthcare
Fri, 10/1/21 - 10:41 am
Massachusetts
hospitals
Biogen
Aduhelm
Alzheimer's disease
Despite rough start, Biogen's Aduhelm should find footing, analysts say. But don't expect much in 2021
Fierce Pharma
Wed, 09/29/21 - 11:58 pm
Biogen
Aduhelm
Alzheimer's disease
Is Cassava Sciences Back in the Game?
Motley Fool
Tue, 09/28/21 - 10:54 am
FDA
Cassava Sciences
simufilam
Alzheimer's disease
Seizing Aduhelm precedent, Biogen, Eisai get the ball rolling on another accelerated Alzheimer's approval
Endpoints
Tue, 09/28/21 - 12:07 am
Biogen
Aduhelm
Eisai
Alzheimer's disease
FDA
lecanemab
Why Shares of Cassava Sciences Rose 15% Today
Motley Fool
Thu, 09/23/21 - 10:48 pm
Cassava Sciences
Alzheimer's disease
simufilam
NIH
Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer's drug Aduhelm
Fierce Pharma
Wed, 09/22/21 - 11:40 pm
Biogen
drug reps
Aduhelm
Alzheimer's disease
Struggling with Alzheimer's launch, Biogen couldn't present 'clear case for growth' outside of Aduhelm: analyst
Fierce Pharma
Wed, 09/22/21 - 12:03 pm
Biogen
Alzheimer's disease
drug launches
Aduhelm
Biogen's Alzheimer's drug Aduhelm slowly gaining steam among prescribing neurologists, study finds
Fierce Pharma
Thu, 09/16/21 - 10:34 pm
Biogen
Aduhelm
Alzheimer's disease
Biogen admits Aduhelm launch ‘slower than we anticipated’
Stat
Thu, 09/9/21 - 11:16 am
Biogen
Aduhelm
drug launches
Alzheimer's disease
Cassava CEO, ‘dazed and confused’, takes to biotech defense handbook by blaming short sellers for woes
Fierce Biotech
Fri, 09/3/21 - 11:18 am
Cassava Sciences
FDA
Alzheimer's disease
New Study Shows Diadem’s AlzoSure Alzheimer’s Blood Test Can Predict Disease Years Before Diagnosis
Xtalks
Thu, 09/2/21 - 10:15 pm
diagnostics
Diadem
AlzoSure
Alzheimer's disease
biomarkers
Biogen's Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprises
Fierce Pharma
Wed, 09/1/21 - 10:48 pm
Biogen
Aduhelm
clinical trials
Alzheimer's disease
Biogen providing Aduhelm for free while waiting for Medicare coverage decision
Beckers Hospital Review
Tue, 08/31/21 - 10:02 pm
Biogen
Aduhelm
Medicare
Alzheimer's disease
AC Immune claims a tau win in Alzheimer’s
EP Vantage
Tue, 08/31/21 - 10:52 am
AC Immune
Alzheimer's disease
semorinemab
clinical trial
Reimbursement begins slowly for Biogen’s expensive Alzheimer’s drug
Endpoints
Mon, 08/30/21 - 11:04 am
Medicare
Biogen
Aduhelm
reimbursement
Alzheimer's disease
Cassava's stock tumbles again, after Quanterix said it 'did not' prepare data charts presented by Cassava, that are under dispute
Marketwatch
Fri, 08/27/21 - 10:46 am
Quanterix
Cassava Sciences
Alzheimer's disease
Mega $3 Billion+ Deal Shapes Up for Roche to Target AD and Parkinson's
BioSpace
Tue, 08/24/21 - 11:12 am
Roche
Shape Therapeutics
RNA editing
RNAfix
Alzheimer's disease
Parkinson's Disease
Elixiron closes $27M series A for Alzheimer's and vitiligo clinical trials
Fierce Biotech
Mon, 08/23/21 - 11:18 pm
Elixiron Immunotherapeutics
funding
Alzheimer's disease
immuno-oncology
Athira Looks to Advance Alzheimer’s, Parkinson’s Disease Research Amid CEO Debacle
BioSpace
Wed, 08/18/21 - 11:01 am
Athira Pharma
CEO
Alzheimer's disease
Parkinson's Disease
R&D
Lilly, with Alzheimer's in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec
Fierce Biotech
Tue, 08/17/21 - 10:26 am
Eli Lilly
reorganization
Loxo Oncology
oncology
Neuroscience
Alzheimer's disease

Pages